Eiffage (FR:FGR) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Eiffage, in partnership with Fouchard and Sner, has secured a €72 million contract to expand and renovate the Henri Becquerel cancer treatment center in Rouen, France. Eiffage’s share of the project, which aims to enhance patient experience with sustainable and energy-efficient designs, is valued at €50 million. Construction has commenced with completion expected by 2026, ensuring continuous patient care during the process.
For further insights into FR:FGR stock, check out TipRanks’ Stock Analysis page.